跳至主要内容
临床试验/NCT03960424
NCT03960424已完成不适用

Diabetes Management Program for Hispanic/Latino

Northwell Health2 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2019年9月30日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
240
试验地点
2
主要终点
Hemoglobin A1C

研究概览

简要总结

To compare Diabetes Telemonitoring to comprehensive outpatient management (COM) on critical patient-centered outcomes, including HbA1c.

详细描述

The investigators propose a multiphase mixed method, Comparative Effectiveness Research Randomized Control Trial (CER RCT) to:

Specific Aim 1: Assess usability of an evidence-based DTM intervention utilizing a Community Based Participatory Research (CBPR) approach and adapt it to facilitate acceptability and feasibility in a population of H/L patients with T2D, and their caregivers and providers.

Specific Aim 2: Assess whether H/L patients receiving DTM attain significantly improved patient-centered outcomes compared to COM, through a CER RCT. Expected outcomes include improved diabetes quality of life (QoL), glucose management (GM), blood pressure (BP), cholesterol, medication adherence, and diabetes self-efficacy (SE), and reduced diabetes distress, problem areas in diabetes (PAID), inpatient utilization, unscheduled T2D physician visits and sick days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Hispanic patients with a diagnosis of diabetes
  • Speaks English or Spanish

排除标准

  • Patient is not Hispanic
  • Patient does not have a diagnosis of diabetes

结局指标

主要结局

Hemoglobin A1C

时间窗: 6 months

HbA1c

次要结局

  • Blood Pressure(6 months)
  • Adherence(6 months)
  • Weight(6 months)
  • Cholesterol(6 months)
  • Diabetes Quality of life(6 months)
  • HbA1c(12 months)
  • Hypoglycemia episodes(6 months)
  • Diabetes self-efficacy(6 months)
  • PAID(6 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验